Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03541369
Title Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (20170528)
Acronym 20170528
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | DEU | CAN | AUS

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
Northwestern University Evanston Illinois 60208 United States Details
Johns Hopkins Baltimore Maryland 21287 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
The Alfred Hospital Melbourne Victoria 3004 Australia Details
The Royal Melbourne Hospital Parkville Victoria 3050 Australia Details
University Health Network-Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden Dresden 01307 Germany Details
Klinikum der Universitaet Muenchen Campus Grosshadern Muenchen 81377 Germany Details
National Cancer Center Hospital East Kashiwa-shi Chiba 277-8577 Japan Details
University of Fukui Hospital Yoshida-gun Fukui 910-1193 Japan Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Severance Hospital Yonsei University Health System Seoul 03722 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field